cicletanine has been researched along with Reperfusion Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Csont, T; Droy-lefaix, MT; Ferdinandy, P; Koltai, M; Szilvássy, Z | 1 |
| Campa, PP; Criniti, A; Dawodu, AA; Monti, F; Picard, S; Puddu, PE; Ruvolo, G | 1 |
2 other study(ies) available for cicletanine and Reperfusion Injury
| Article | Year |
|---|---|
Cardioprotective effect of enantiomers of cicletanine (BN50417, BN50418) in ischaemic/reperfused isolated working rat hearts: interaction with glibenclamide.
Topics: Animals; Antihypertensive Agents; Drug Interactions; Glyburide; Heart; Heart Function Tests; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardium; Protective Agents; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Stereoisomerism; Ventricular Fibrillation | 1999 |
Cicletanine prevents the excitation-conduction blocks induced by terfenadine in ischemic myocardium.
Topics: Animals; Anti-Arrhythmia Agents; Dimethyl Sulfoxide; Drug Interactions; Epoprostenol; Female; Guinea Pigs; Heart Conduction System; Histamine H1 Antagonists; In Vitro Techniques; Indomethacin; Multivariate Analysis; Myocardial Ischemia; Pyridines; Random Allocation; Reperfusion Injury; Terfenadine; Time Factors | 1999 |